Ageing and longevity are related to growth hormone/insulin-like growth factor-1 secretion

被引:30
|
作者
Ruiz-Torres, A [1 ]
Kirzner, MSD [1 ]
机构
[1] Univ Autonoma Madrid, Res Inst Gerontol & Metab, Madrid, Spain
关键词
ageing; parameters; longevity; insulin-like growth factor-1; testosterone; lean body mass;
D O I
10.1159/000065507
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. It is known that the growth process is related to an individual's life-span, but the role of growth hormone (GH) secretion in human ageing remains unknown. Objectives: This study has focussed on the influence of GH on ageing parameters and on its relationship with human longevity. Methods: To deal with the first issue, we compared ageing parameters of young (up to 39) and old (over 70) individuals having similar insulin-like growth factor-1 (IGF-1) blood levels. For the second one, the decline in IGF-1 levels was studied comparing its behaviour in the first half with that in the second half of adult life. The latter represents the period of life in which mortality progressively increases. Two hundred and five healthy individuals were chosen as subjects, well distributed by gender and age (between 19 and 93 years). Results: Old males with IGF-1 levels similar to young ones do not show the age-dependent decrease in serum testosterone and lean body mass, nor the increase in fat body mass. Other hormone-metabolic and nutritional parameters do not reveal any change compared with the results of all individuals. In females, the results do not allow to assume any IGF-1 influence. The behaviour of the linear regression in the second half of adult life of males, which becomes flat because old men having low IGF-1 blood levels die earlier, is consistent with these results. This effect, which is supported by predictive analysis, is not observed in females, i.e. the IGF-1 level declines in the second half of the women's adult life are only a little flatter than in the first half. Finally, extrapolating the regressions obtained in the first half of adulthood, the age at which the curve crosses the x-axis is 110 years for males and 132 for females. Conclusion: The presented study of IGF-1 levels suggests that the GH secretion in adulthood plays a determinant role not only for some regressive manifestations, but also for life potential. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 50 条
  • [41] SHOX Gene Variants: Growth Hormone/Insulin-Like Growth Factor-1 Status and Response to Growth Hormone Treatment
    Shapiro, Sofia
    Klein, Genna W.
    Klein, Michelle L.
    Wallach, Elizabeth J.
    Fen, Ye
    Godbold, James H.
    Rapaport, Robert
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2015, 83 (01): : 26 - 35
  • [42] Estradiol effects on the growth hormone/insulin-like growth factor-1 axis in amenorrheic athletes
    Waters, DL
    Dorin, RI
    Qualls, CR
    Ruby, BC
    Baumgartner, RN
    Robergs, RA
    [J]. CANADIAN JOURNAL OF APPLIED PHYSIOLOGY-REVUE CANADIENNE DE PHYSIOLOGIE APPLIQUEE, 2003, 28 (01): : 64 - 78
  • [43] The aging brain: is function dependent on growth hormone/insulin-like growth factor-1 signaling?
    B. A. Forshee
    [J]. AGE, 2006, 28 : 173 - 180
  • [44] The Somatotrope Growth Hormone-Releasing Hormone/Growth Hormone/Insulin-Like Growth Factor-1 Axis in Immunoregulation and Immunosenescence
    Bodart, Gwennaelle
    Farhat, Khalil
    Charlet-Renard, Chantal
    Salvatori, Roberto
    Geenen, Vincent
    Martens, Henri
    [J]. ENDOCRINE IMMUNOLOGY, 2017, 48 : 147 - 159
  • [45] Evaluation of Insulin-Like Growth Factor-1 in Indian Growth Hormone-Deficient Children on Growth Hormone Therapy
    Ekbote, Veena H.
    Rustagi, Vaishakhi T.
    Khadilkar, Vaman V.
    Khadilkar, Anuradha V.
    Chiplonkar, Shashi A.
    [J]. ENDOCRINE RESEARCH, 2011, 36 (03) : 109 - 115
  • [46] Effects of growth hormone and insulin-like growth factor-1 on cardiac hypertrophy of hypertensive patients
    Sesti, Giorgio
    Sciacqua, Angela
    Scozzafava, Angela
    Vatrano, Marco
    Angotti, Elvira
    Ruberto, Carmen
    Santillo, Elpidio
    Parlato, Giuseppe
    Perticone, Francesco
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 (02) : 471 - 477
  • [47] Effects of Growth Hormone and Insulin-Like Growth Factor-1 on Postoperative Muscle and Substrate Metabolism
    Hammarqvist, Folke
    Wennstrom, Ingmar
    Wernerman, Jan
    [J]. JOURNAL OF NUTRITION AND METABOLISM, 2010, 2010
  • [48] Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly
    Bian, Ailin
    Ma, Yue
    Zhou, Xinzi
    Guo, Ying
    Wang, Wenyi
    Zhang, Yiran
    Wang, Xiaofei
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2020, 21 (01)
  • [49] Role of the growth hormone/insulin-like growth factor-1 paracrine axis in rheumatic diseases
    Denko, CW
    Malemud, CJ
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (01) : 24 - 34
  • [50] Treatment with growth hormone and insulin-like growth factor-1 in septicemia: Effects on carbohydrate metabolism
    Balteskard, L
    Unneberg, K
    Mjaaland, M
    Sager, G
    Jenssen, TG
    Revhaug, A
    [J]. EUROPEAN SURGICAL RESEARCH, 1998, 30 (02) : 79 - 94